Gene · 2355
Papers2,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,749
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FeaSion decodes the regulatory landscape and functional diversity of RNA polymerase II CTD phosphorylation. | Sci Adv | 2025 | 41313762 | PubTator, text mining | PubMed |
| Fosl2 regulates the transition from parietal epithelial cells to myofibroblasts in the kidney. | bioRxiv | 2025 | 41292842 | PubTator, text mining | PubMed |
| Chromatin remodeling enhances MAP3K8 expression in HAM: a key pathogenesis for therapeutic intervention. | Nat Commun | 2025 | 41213906 | PubTator, text mining | PubMed |
| Synovial CXCL3+FOSL2+ Macrophages Mediate Inflammation via FOSL2/AP-1 in Rheumatoid Arthritis: A Single-Cell Transcriptome Analysis. | Int J Mol Sci | 2025 | 41096984 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis uncovers a novel FOSL2-COL8A1-EMT regulatory axis driving colorectal cancer progression. | Biochem Biophys Res Commun | 2025 | 41086679 | PubTator, text mining | PubMed |
| Integration of scRNA-Seq and scATAC-Seq Reveals Malignant Characteristics of Sarcomatoid Clear Cell Renal Cell Carcinoma. | Cancer Sci | 2025 | 41082386 | PubTator, text mining | PubMed |
| FET fusion oncoproteins enrich SWI/SNF complex subtypes and interaction partners. | Cell Mol Biol Lett | 2025 | 40988026 | PubTator, text mining | PubMed |
| RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticity. | Nat Commun | 2025 | 40962798 | PubTator, text mining | PubMed |
| BDH2-driven lysosome-to-mitochondria iron transfer shapes ferroptosis vulnerability of the melanoma cell states. | Nat Metab | 2025 | 40957995 | PubTator, text mining | PubMed |
| A double-negative prostate cancer subtype is vulnerable to SWI/SNF-targeting degrader molecules. | bioRxiv | 2025 | 40949972 | PubTator, text mining | PubMed |
| Multi-level validation of high expression of PLAUR, FOSL2, and SLC11A1 in aortic dissection and their clinical implications. | Int Immunopharmacol | 2025 | 40902395 | PubTator, text mining | PubMed |
| Exploring the epigenetic modifications of the RONS-TRPA1-CGRP axis in migraine pathophysiology. | J Headache Pain | 2025 | 40890590 | PubTator, text mining | PubMed |
| Cellular cartography reveals mouse prostate organization and determinants of castration resistance. | Proc Natl Acad Sci U S A | 2025 | 40854129 | PubTator, text mining | PubMed |
| Regulation of cisplatin resistance in lung cancer by epigenetic mechanisms. | Clin Epigenetics | 2025 | 40851017 | PubTator, text mining | PubMed |
| IRF2BPL inhibits proliferation, migration and invasion of osteosarcoma cells by inhibiting FOSL2-mediated PI3K/AKT pathway activation. | Cell Signal | 2025 | 40834975 | PubTator, text mining | PubMed |
| The effect of travoprost on primary human limbal epithelial cells and the siRNA-based aniridia limbal epithelial cell model, in vitro. | PLoS One | 2025 | 40828815 | PubTator, text mining | PubMed |
| The fibrosis puzzle of systemic sclerosis-associated ILD and the quest for targeted interventions. | Ther Adv Respir Dis | 2025 | 40817801 | PubTator, text mining | PubMed |
| Integrative snRNA-seq, molecular docking and dynamics simulations identifies Lasmiditan as drug candidate for Alzheimer's disease. | Clin Transl Med | 2025 | 40817596 | PubTator, text mining | PubMed |
| Identification of a prognostic signature consisting of three macrophage-related genes for glioblastoma based on bulk and single-cell transcriptomes analyses. | Ann Med | 2025 | 40810678 | PubTator, text mining | PubMed |
| 3D Tumor microenvironment interaction reveals AP-1 complex regulation and contact-mediated reprogramming of bone marrow stromal cells in chronic lymphocytic leukemia. | Hemasphere | 2025 | 40809351 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2355/papers?page=5